This is not the most recent version of the article. View current version (14 JUL 2015)

Overview of Reviews Protocol

You have free access to this content

Interventions for bronchiectasis: an overview of Cochrane systematic reviews

  1. Emma J Welsh1,*,
  2. Sally Spencer2,
  3. Tarek Saba3,
  4. David J Evans4,5,
  5. Stephen J Fowler6,7

Editorial Group: Cochrane Airways Group

Published Online: 28 FEB 2013

DOI: 10.1002/14651858.CD010337


How to Cite

Welsh EJ, Spencer S, Saba T, Evans DJ, Fowler SJ. Interventions for bronchiectasis: an overview of Cochrane systematic reviews (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 2. Art. No.: CD010337. DOI: 10.1002/14651858.CD010337.

Author Information

  1. 1

    St George's, University of London, Population Health Sciences and Education, London, UK

  2. 2

    Lancaster University, Faculty of Health and Medicine, Lancaster, Lancashire, UK

  3. 3

    Blackpool Victoria Hospital, Chest Clinic, Blackpool, UK

  4. 4

    Hemel Hempstead Hospital, Thoracic Medicine, Hemel Hempstead, Herts, UK

  5. 5

    Harefield Hospital, Harefield, UK

  6. 6

    Lancashire Teaching Hospitals NHS Trust, Preston, UK

  7. 7

    University of Manchester, Manchester, UK

*Emma J Welsh, Population Health Sciences and Education, St George's, University of London, Cranmer Terrace, London, SW17 0RE, UK. ewelsh@sgul.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 28 FEB 2013

SEARCH

This is not the most recent version of the article. View current version (14 JUL 2015)

References

Additional references

Balshem 2011
Becker 2011
  • Becker LA, Oxman AD. Chapter 22: Overviews of reviews. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Chang 2003
Chang 2007
  • Chang CC, Morris PS, Chang AB. Influenza vaccine for children and adults with bronchiectasis. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD006218.pub2]
Chang 2010
  • Chang AB, Bell SC, Byrnes CA, Grimwood K, Holmes P, King PT, et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. Thoracic Society of Australia and New Zealand (TSANZ) and Australian Lung Foundation (ALF) 2010:http://www.lungnet.org.au/professional-resources/guidelines/chronic-suppurative-lung-diseaseanz-2010 (accessed DDMMYYYY).
Clark 1989
  • Clarke SW. Rationale of airway clearance. European Respiratory Journal - Supplements 1989;7:599s-603s.
Cole 1986
  • Cole PJ. Inflammation: a two-edged sword - the model of bronchiectasis. European Journal of Respiratory Diseases 1986;69 (Suppl 147):6-15.
Cole 1997
Corless 2000
  • Corless JA, Warburton CJ. Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD002174]
Crockett 2001
  • Crockett A, Cranston JM, Alpers JH, Latiner KM. Mucolytics for bronchiectasis. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD001289]
Crosbie 2009
Evans 1996
Evans 2003
Evans 2007
  • Evans DJ, Bara A, Greenstone M. Prolonged antibiotics for purulent bronchiectasis in children and adults. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD001392.pub2]
Franco 2003
  • Franco F, Sheikh A, Greenstone M. Short acting beta2-agonists for bronchiectasis. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD003572]
Goeminne 2012
  • Goeminne PC, Scheers H, Decraene A, Seys S, Dupont LJ. Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients. Respiratory Research 2012;13:21.
Habesoglu 2011
  • Habesoglu MA, Ugurlu AO, Eyuboglu FO. Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis. Annals of Thoracic Medicine 2011; Vol. 6, issue 3:131-6.
Higgins 2011
  • Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
HPA 2012
  • Health Protection Agency Guidelines. http://www.hpa.org.uk/web/HPAweb&Page&HPAwebAutoListName/Page/1204012992944 (accessed 11 July 2012).
Kapur 2007
  • Kapur N, Chang AB. Oral non steroid anti-inflammatories for children and adults with bronchiectasis. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006427.pub2]
Martinez-Garcia 2007
  • Martinez-Garcia, Soler-Cataluna JJ, Perpin a-Tordera M, Roman-Sanchez P, Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007;132(5):1565-72.
Nair 2012
O'Donnell 1998
Pasteur 2000
  • Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, et al. An investigation into causative factors in patients with bronchiectasis. American Journal of Respiratory and Critical Care Medicine 2000;162:1277-84.
Pasteur 2010
  • Pasteur MC, Bilton D, Hill AT, on behalf of the British Thoracic Society Bronchiectasis (non-CF) Guideline Group. British Thoracic Society Guidelines for non-CF bronchiectasis. Thorax 2010;65(Suppl 1):i1-i58.
Restrepo 2007
  • Restrepo RD. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?. Respiratory Care 2007;52(9):1173-5.
Roberts 2010
Seitz 2010
  • Seitz AE, Olivier KN, Steiner CA, Montes de Oca R, Holland SM, Prevots DR. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest 2010;138:944-9.
Seitz 2012
  • Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots DR. Trends in bronchiectasis among medicare beneficiaries in the United States, 2000-2007. Chest 2012; Vol. 142, issue 2:432-9.
Shea 2007
  • Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology 2007;7:10.
Sheikh 2001
  • Sheikh A, Nolan D, Greenstone M. Long-acting beta2-agonists for bronchiectasis. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD002155]
Steele 2000
Warburton 2000
  • Warburton CJ, Corless JA. Surgery versus non-surgical treatment for bronchiectasis. Cochrane Database of Systematic Reviews 2000, Issue 4. [DOI: 10.1002/14651858.CD002180]
Weycker 2005
  • Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and economic burden of bronchiectasis. Clinical Pulmonary Medicine 2005;12:205-9.
Wilson 1997a
  • Wilson CB. Jones PW, O'Leary CJ, Cole PJ, Wilson R. Validation of the St. George's Respiratory Questionnaire in bronchiectasis. American Journal of Respiratory and Critical Care Medicine 1997;156:536-41.
Wilson 1997b
  • Wilson CB, Jones PW, O'Leary CJ, Hansell DM, Cole PJ, Wilson R. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. European Respiratory Journal 1997;10:1754-60.